Literature DB >> 21297648

Movement disorders in 2010: Parkinson disease-symptoms and treatments.

Marie Vidailhet1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21297648     DOI： 10.1038/nrneurol.2010.216

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

Authors:  Stéphane Thobois; Claire Ardouin; Eugénie Lhommée; Hélène Klinger; Christelle Lagrange; Jing Xie; Valérie Fraix; Maria Clara Coelho Braga; Rachid Hassani; Andrea Kistner; Alexandra Juphard; Eric Seigneuret; Stephan Chabardes; Patrick Mertens; Gustavo Polo; Anthonin Reilhac; Nicolas Costes; Didier LeBars; Marc Savasta; Léon Tremblay; Jean-Louis Quesada; Jean-Luc Bosson; Alim-Louis Benabid; Emmanuel Broussolle; Pierre Pollak; Paul Krack
Journal:  Brain       Date:  2010-03-17       Impact factor: 13.501

3.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.

Authors:  Carine Karachi; David Grabli; Frédéric A Bernard; Dominique Tandé; Nicolas Wattiez; Hayat Belaid; Eric Bardinet; Annick Prigent; Hans-Peter Nothacker; Stéphane Hunot; Andreas Hartmann; Stéphane Lehéricy; Etienne C Hirsch; Chantal François
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

4.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

5.  Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.

Authors:  M U Ferraye; B Debû; V Fraix; L Goetz; C Ardouin; J Yelnik; C Henry-Lagrange; E Seigneuret; B Piallat; P Krack; J-F Le Bas; A-L Benabid; S Chabardès; P Pollak
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

6.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

7.  History of falls in Parkinson disease is associated with reduced cholinergic activity.

Authors:  N I Bohnen; M L T M Müller; R A Koeppe; S A Studenski; M A Kilbourn; K A Frey; R L Albin
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

8.  Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons.

Authors:  B Piallat; S Chabardès; N Torres; V Fraix; L Goetz; E Seigneuret; E Bardinet; M Ferraye; B Debu; P Krack; J Yelnik; P Pollak; A L Benabid
Journal:  Neuroscience       Date:  2008-10-31       Impact factor: 3.590
  8 in total
  6 in total

1.  Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.

Authors:  Meng Wang; Chengliang Lu; Fred Roisen
Journal:  Stem Cells Transl Med       Date:  2012-06-01       Impact factor: 6.940

Review 2.  Vertebrate food products as a potential source of prion-like α-synuclein.

Authors:  Bryan Andrew Killinger; Viviane Labrie
Journal:  NPJ Parkinsons Dis       Date:  2017-11-24

3.  Functional Outcome of Bilateral Subthalamic Nucleus-Deep Brain Stimulation in Advanced Parkinson's Disease Patients: A Prospective Study.

Authors:  Swetha Tandra; Balakrishna Ramavath; Rukmini Mridula Kandadai; S A Jabeen; Meena A Kannan; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

4.  The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review.

Authors:  Xing-Ru Zhang; Zhi-Yu Jiang; Zeng-Rui Zhang; Hui-Jun Chen; Ke Wu; Jin-Cai He; Cheng-Long Xie
Journal:  Drug Des Devel Ther       Date:  2020-02-26       Impact factor: 4.162

Review 5.  Effects of neurostimulation for advanced Parkinson's disease patients on motor symptoms: A multiple-treatments meta-analysas of randomized controlled trials.

Authors:  Cheng-Long Xie; Bei Shao; Jie Chen; Yi Zhou; Shi-Yi Lin; Wen-Wen Wang
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

6.  Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials.

Authors:  Fan Xu; Wenbin Ma; Yongmin Huang; Zhihai Qiu; Lei Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-22       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.